Krizner, Joelle

Krizner, Joelle was paid $67K by Medicaid between Nov 2019 and Dec 2020, across 10 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 88% of everything it billed.

33Billing provider infoKRIZNER, JOELLE
MURFREESBORO, TN 37128

33aNPI1124159710assigned 03/08/2007

33bProvider typeNurse Practitioner

28Total paid$67K

24GClaims2,786

24DCodes billed10

24AFirst – last monthNov 2019 – Dec 2020

Compared with peers

Next to other Nurse Practitioner providers in Tennessee

Rank by total paid#65 of 212

Median peer was paid$17K

This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	119	$3K
2020	2,667	$64K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	88%	1,972	1,819	$59K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	6.1%	492	469	$4K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	1.9%	47	46	$1K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.4%	42	40	$927.14
72110		<1%	60	52	$601.45
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	38	37	$597.47
20610		<1%	26	24	$464.54
72190		<1%	13	12	$86.36
82948		<1%	32	28	$26.03
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	64	54	$16.83

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.